Biohaven (BHVN) Times Interest Earned (2021 - 2026)
Biohaven (BHVN) reported Times Interest Earned of -$11.97 for Q1 2026, down 639.26% on a YoY basis from $2.22 in Q1 2025, and down 333.42% sequentially from -$2.76 in Q3 2025.
Biohaven (BHVN) Times Interest Earned (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Times Interest Earned data on file, last reported at -$11.97 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 639.26% year-over-year to -$11.97; the trailing twelve-month figure through Mar 2026 stood at -$60.05 (down 789.72% YoY), and the FY2025 full-year result was -$2.38, up 18.37% from the prior year.
- Times Interest Earned eased to -$11.97 in Q1 2026, from -$2.76 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.36 in Q1 2024 to a low of -$1285.4 in Q3 2023.
- A 5-year average of -$135.65 and a median of -$2.76 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned sank 11926.26% in 2023 and jumped 99.97% in 2024, its largest moves.
- Tracing BHVN's Times Interest Earned over 5 years: stood at -$0.99 in 2022, then soared by 40.02% to -$0.59 in 2023, then decreased by 5.55% to -$0.63 in 2024, then tumbled by 341.7% to -$2.76 in 2025, then slumped by 333.42% to -$11.97 in 2026.
- Business Quant data shows BHVN's Times Interest Earned at -$11.97 in Q1 2026, -$2.76 in Q3 2025, and -$3.71 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -11.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.97 |
| Sep 30, 2025 | -2.76 |
| Jun 30, 2025 | -3.71 |
| Mar 31, 2025 | -1.62 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -1.30 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | -0.59 |
| Sep 30, 2023 | -1,285.43 |
| Jun 30, 2023 | -356.10 |
| Mar 31, 2023 | -238.60 |
| Dec 31, 2022 | -0.99 |
| Sep 30, 2022 | -10.69 |
| Jun 30, 2022 | -119.53 |
| Dec 31, 2021 | -0.94 |